What is Semler Scientific?
Semler Scientific, Inc. is dedicated to developing, manufacturing, and marketing innovative products and services aimed at assisting healthcare providers in evaluating and treating chronic diseases. Its flagship product, QuantaFlo®, is a patented and FDA-cleared rapid point-of-care test designed to measure arterial blood flow in the extremities. This technology aids in the diagnosis of peripheral arterial disease, enabling healthcare providers to better assess patients' risk for heart attacks and strokes. Semler Scientific believes its offerings provide valuable insights to insurance companies and physicians, thereby facilitating improved patient care and management.
How much funding has Semler Scientific raised?
Semler Scientific has raised a total of $31.5M across 2 funding rounds:
Stock Offering
$10M
Share Placement
$21.5M
Stock Issuance/Offering (2014): $10M, investors not publicly disclosed
Share Placement (2024): $21.5M, investors not publicly disclosed
What's next for Semler Scientific?
The recent major strategic investment signifies a pivotal moment for Semler Scientific, likely indicating a transition towards scaling its operations and expanding market reach. This substantial backing suggests confidence from investors in the company's technology and its potential to disrupt the diagnostics market. Semler Scientific is poised to leverage this financing to further develop its product pipeline, enhance its sales and marketing efforts, and potentially explore new therapeutic areas. The company's strategic focus on addressing critical chronic diseases positions it for sustained expansion and increased market share in the healthcare technology landscape.
See full Semler Scientific company page
